LPCN — Lipocine Inc · rev $309.5K

Lipocine Inc (LPCN) is a biotechnology company listed on NASDAQ.

Latest reported LPCN revenue for 2026-06-30 was $309.5K. Net income was -$6.3M. LPCN currently screens at market cap $19.3M.

Use this LPCN page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the LPCN quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the LPCN SEC filings page. Lician reads the product cache first so this HTML stays unique to Lipocine Inc even when a live quote feed is slow.

Lipocine Inc latest statements (FY2025)

Latest cached year on this hub. Full LPCN income, balance, and cash tables.

  • Revenue$2.0M
  • Net Income-$9.6M
  • Total Assets$17.0M
  • Total Debt$0
  • Free Cash Flow$0

LPCN recent filings